Intuitive Surgical financials
$412.18−0.63%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B | $4.36B | $4.48B | $3.72B | $3.14B | $2.71B |
| Gross profit | $6.64B | $5.63B | $4.73B | $4.20B | $3.96B | $2.86B | $3.11B | $2.60B | $2.20B | $1.89B |
| Gross margin | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% | 65.6% | 69.4% | 69.9% | 70.2% | 69.9% |
| Operating income | $2.95B | $2.35B | $1.77B | $1.58B | $1.82B | $1.05B | $1.37B | $1.20B | $1.06B | $949.7M |
| Net income | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B | $1.06B | $1.38B | $1.13B | $670.9M | $738.3M |
| Net margin | 28.4% | 27.8% | 25.2% | 21.3% | 29.9% | 24.3% | 30.8% | 30.3% | 21.4% | 27.3% |
| Diluted EPS | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 | $3.85 | $3.16 | $1.92 | $2.09 |
| EBITDA | $3.62B | $2.85B | $2.22B | $1.97B | $2.15B | $1.34B | $1.59B | $1.33B | $1.17B | $1.05B |
| Operating cash flow | $3.03B | $2.42B | $1.81B | $1.49B | $2.09B | $1.48B | $1.60B | $1.17B | $1.14B | $1.09B |
| Free cash flow | $2.49B | $1.30B | $749.6M | $958.4M | $1.75B | $1.14B | $1.17B | $982.2M | $953.2M | $1.03B |
| Diluted shares | 362.7M | 362.0M | 357.4M | 362.0M | 365.8M | 361.0M | 358.4M | 356.4M | 348.9M | 353.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.37B | $2.03B | $2.75B | $1.58B | $1.29B | $1.62B |
| Short-term investments | $2.57B | $1.99B | $2.47B | $2.54B | $2.91B | $3.49B |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $20.46B | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B |
| Total liabilities | $2.52B | $2.21B | $2.04B | $1.86B | $1.60B | $1.41B |
| Shareholders' equity | $17.94B | $16.53B | $13.40B | $11.11B | $11.95B | $9.76B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology